Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Every week in the UK at least 12 young people die of undiagnosed heart conditions. Since its formation in 1995, Cardiac Risk in the Young (CRY) has been working to reduce the frequency of young sudden cardiac death (YSCD). CRY supports young people diagnosed with potentially life-threatening cardiac conditions and offers bereavement support to families affected by YSCD. CRY promotes and develops… View more
Image
Author(s): Koji Hasegawa , Masayuki Yoshida Added: 6 years ago
This video was supplied by the International Society of Cardiovascular Pharmacotherapy (ISCP) and discusesCardiovascular risk management of diabetes and SGLT2 inhibitors Lecturer: Masayuki Yoshida, Professor of Medicine, Tokyo Medical and Dental University, Japan Interviewer： Koji Hasegawa, Leader, Cardiovascular Clinical Research Network, National Hospital Organization,Shizuoka, Japan View more

Heart Failure

Prevention & Chronic Conditions
HF 22: SCD Risk Protection for Newly Diagnosed HF Patients
Author(s): José González-Costello Added: 1 year ago
In this short interview, Dr José González-Costello (University Hospital of Bellvitge, Barcelona, ES) talks about SCD risk protection for newly diagnosed HF patients. Questions 1. How important is SCD risk protection nowadays? 2. What long term treatment do these patients need? 3. What do you recommend to protect patients in the early phase? Recorded at Heart Failure 2022, Madrid. Videographers… View more

Heart Failure

Electrophysiology & Arrhythmia
Risk For Heart Failure Modulate The Effectiveness Of Empagliflozin ? with Javed Butler
Author(s): Javed Butler Added: 6 years ago
This interview with Javed Butler from Stony Brook University, New York, USA discusses Does the Risk for Heart Failure Modulates the Effectiveness of Empagliflozin on Heart Failure Hospitalization or Cardiovascular Death in Patients with Type 2 Diabetes without Heart Failure? Filmed by Radcliffe Cardiology on-site at ESC 2017. View more

Heart Failure

Prevention & Chronic Conditions
Author(s): Oliver Weingärtner , Added: 2 years ago
Join us for this live broadcast where faculty will ensure physicians based in Malaysia are aware of the importance of risk stratification in relation to secondary prevention and how this is dealt with in the recent ESC guidance and why it's important. The faculty will make a distinct comparison between the ESC guidelines and what the Malaysian guidelines say is central to this, including why is… View more

Heart Failure
Author(s): Nicolas M Van Mieghem Added: 6 years ago
In this video, Dr Nicolas Van Mieghem discusses the question; 'are we ready to be doing TAVR in low risk patients?'. View more

Intervention
EASD 23: Epidemiologic Trends & Disparities in Diabetes Risk Among LGBTQ+ Population
Author(s): Carl Streed Added: 6 months ago
EASD 2023 – Dr Carl G Streed (Boston University School of Medicine, US) joins us to summarise healthcare disparities among the LGBTQ+ population.In this interview, Dr Streed discusses the available evidence and explains the minority stress model. This model suggests that experiences of discrimination and stress contribute to worse health outcomes in the LGBTQ community. This can lead to mental… View more

Demographic

Prevention & Chronic Conditions
30-Day Risk Standardized Mortality discusses with Ambarish Pandey
Author(s): Ambarish Pandey Added: 6 years ago
Ambarish Pandey discusses the GWTG-HF Registry -30-Day Risk Standardized Mortality and Long-Term Survival After HF Hospitalization Filmed by Radcliffe Cardiology on-site at theACC 2018 congress in Orlando, US View more

Heart Failure
Author(s): Nicolas M Van Mieghem Added: 6 years ago
In this video, Dr Nicolas Van Mieghem discusses which patients he is performing TAVR in now. View more

Intervention
ESC 2018: Rationale for New Treatment Options for Intermediate-High Risk PE Patients
Author(s): Nicolas Meneveau , Andrew SP Sharp , Adriaan Kraaijeveld Added: 5 years ago
Acoustic pulse thrombolysis treatment for pulmonary embolism patients: rationale, experience and data Satellite symposium at ESC Congress 2018 sponsored by EKOS Corporation Part 1: Prof Nicolas Meneveau - (Besancon, FR) Part 2: Prof Andrew Sharp - (Exeter, UK) Part 3: Prof Adriaan Kraaijeveld - (Utrecht, NL) View more

Imaging & Diagnostics

Intervention